LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 29

Search options

  1. Article ; Online: Meningitis por Streptococcus salivarus tras anestesia subaracnoidea.

    Cervero, Miguel

    Enfermedades infecciosas y microbiologia clinica

    2009  Volume 27, Issue 6, Page(s) 371–372

    Title translation Streptococcus salivarus meningitis following subarachnoid anesthesia.
    MeSH term(s) Anesthesia, Spinal/adverse effects ; Gloves, Protective ; Humans ; Iatrogenic Disease ; Infectious Disease Transmission, Professional-to-Patient/prevention & control ; Masks ; Meningitis, Bacterial/etiology ; Meningitis, Bacterial/microbiology ; Meningitis, Bacterial/prevention & control ; Streptococcal Infections/etiology ; Streptococcal Infections/prevention & control ; Subarachnoid Space ; Viridans Streptococci/isolation & purification ; Viridans Streptococci/pathogenicity ; Virulence ; Wound Infection/microbiology ; Wound Infection/prevention & control
    Language Spanish
    Publishing date 2009-06
    Publishing country Spain
    Document type Letter
    ZDB-ID 1070941-1
    ISSN 1578-1852 ; 0213-005X
    ISSN (online) 1578-1852
    ISSN 0213-005X
    DOI 10.1016/j.eimc.2008.11.003
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Amikacin pharmacokinetics in elderly patients with severe infections.

    Medellín-Garibay, Susanna E / Romano-Aguilar, Melissa / Parada, Alejandro / Suárez, David / Romano-Moreno, Silvia / Barcia, Emilia / Cervero, Miguel / García, Benito

    European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences

    2022  Volume 175, Page(s) 106219

    Abstract: Objective: The aim of this study was to characterize the population pharmacokinetics of amikacin in elderly patients by means of nonlinear mixed effects modelling and to propose initial dosing schemes to optimize therapy based on PK/PD targets.: ... ...

    Abstract Objective: The aim of this study was to characterize the population pharmacokinetics of amikacin in elderly patients by means of nonlinear mixed effects modelling and to propose initial dosing schemes to optimize therapy based on PK/PD targets.
    Method: A total of 137 elderly patients from 65 to 94 years receiving intravenous amikacin and routine therapeutic drug monitoring at Hospital Universitario Severo Ochoa were included. Concentration-time data and clinical information were retrospectively collected; initial doses of amikacin ranged from 5.7 to 22.5 mg/kg/day and each patient provided between 1 and 10 samples.
    Results: Amikacin pharmacokinetics were best described by a two-compartment open model; creatinine clearance (CrCL) was related to drug clearance (2.75 L/h/80 mL/min) and it was augmented 28% when non-steroidal anti-inflammatory drugs were concomitantly administered. Body mass index (BMI) influenced the central volume of distribution (17.4 L/25 kg/m
    Conclusion: Initial dosing approach for amikacin was designed for elderly patients based on nonlinear mixed effects modeling to maximize the probability to attain efficacy and safety targets considering individual BMI and CrCL.
    MeSH term(s) Administration, Intravenous ; Aged ; Amikacin ; Anti-Bacterial Agents ; Humans ; Metabolic Clearance Rate ; Retrospective Studies
    Chemical Substances Anti-Bacterial Agents ; Amikacin (84319SGC3C)
    Language English
    Publishing date 2022-05-23
    Publishing country Netherlands
    Document type Journal Article
    ZDB-ID 1154366-8
    ISSN 1879-0720 ; 0928-0987
    ISSN (online) 1879-0720
    ISSN 0928-0987
    DOI 10.1016/j.ejps.2022.106219
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: HIV medical care interruption among people living with HIV in Spain, 2004-2020.

    Izquierdo, Rebeca / Rava, Marta / Moreno-García, Estela / Blanco, José Ramón / Asensi, Víctor / Cervero, Miguel / Curran, Adrian / Rubio, Rafael / Iribarren, José Antonio / Jarrín, Inmaculada

    AIDS (London, England)

    2023  Volume 37, Issue 8, Page(s) 1277–1284

    Abstract: Objective: We estimated the incidence rate of HIV medical care interruption (MCI) and its evolution over a 16-year-period, and identified associated risk factors among HIV-positive individuals from the Cohort of the Spanish AIDS Research Network in 2004- ...

    Abstract Objective: We estimated the incidence rate of HIV medical care interruption (MCI) and its evolution over a 16-year-period, and identified associated risk factors among HIV-positive individuals from the Cohort of the Spanish AIDS Research Network in 2004-2020.
    Design: We included antiretroviral-naive individuals aged at least 18 years at enrolment, recruited between January 1, 2004, and August 30, 2019, and followed-up until November 30, 2020.
    Methods: Individuals with any time interval of at least 15 months between two visits were defined as having a MCI. We calculated the incidence rate (IR) of having at least one MCI and used multivariable Poisson regression models to identify associated risk factors.
    Results: Of 15 274 individuals, 5481 (35.9%) had at least one MCI. Of those, 2536 (46.3%) returned to HIV care after MCI and 3753 (68.5%) were lost to follow-up at the end of the study period. The incidence rate (IR) of MCI was 7.2/100 person-years (py) [95% confidence interval (CI): 7.0-7.4]. The annual IR gradually decreased from 20.5/100 py (95% CI: 16.4-25.6) in 2004 to 4.9/100 py (95% CI: 4.4-5.5) in 2014, a slight increase was observed between 2015 and 2018, reaching 9.3/100 py (95% CI: 8.6-10.2) in 2019. Risk factors for MCI included younger age, lower educational level, having contracted HIV infection through injecting drug use or heterosexual intercourse, having been born outside of Spain, and CD4 + cell count >200 cell/μl, viral load <100 000 and co-infection with hepatitis C virus at enrolment.
    Conclusions: Around a third of individuals had at least one MCI during the follow-up. Identified predictors of MCI can help health workers to target and support most vulnerable individuals.
    MeSH term(s) Humans ; Adolescent ; Adult ; HIV Infections/drug therapy ; Spain/epidemiology ; Risk Factors ; Anti-Retroviral Agents/therapeutic use ; Hepatitis C/drug therapy ; CD4 Lymphocyte Count ; Incidence
    Chemical Substances Anti-Retroviral Agents
    Language English
    Publishing date 2023-03-21
    Publishing country England
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 639076-6
    ISSN 1473-5571 ; 0269-9370 ; 1350-2840
    ISSN (online) 1473-5571
    ISSN 0269-9370 ; 1350-2840
    DOI 10.1097/QAD.0000000000003552
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article: Beneficial Effect of Short-Term Supplementation of High Dose of Vitamin D

    Cervero, Miguel / López-Wolf, Daniel / Casado, Guiomar / Novella-Mena, Maria / Ryan-Murua, Pablo / Taboada-Martínez, María Luisa / Rodríguez-Mora, Sara / Vigón, Lorena / Coiras, Mayte / Torres, Montserrat

    Frontiers in pharmacology

    2022  Volume 13, Page(s) 863587

    Abstract: There is now sufficient evidence to support that vitamin D deficiency may predispose to SARS-CoV-2 infection and increase COVID-19 severity and mortality. It has been suggested that vitamin ... ...

    Abstract There is now sufficient evidence to support that vitamin D deficiency may predispose to SARS-CoV-2 infection and increase COVID-19 severity and mortality. It has been suggested that vitamin D
    Language English
    Publishing date 2022-07-04
    Publishing country Switzerland
    Document type Journal Article
    ZDB-ID 2587355-6
    ISSN 1663-9812
    ISSN 1663-9812
    DOI 10.3389/fphar.2022.863587
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: Predictors of low-level HIV viraemia and virological failure in the era of integrase inhibitors: A Spanish nationwide cohort.

    Álvarez, Hortensia / Rava, Marta / Martínez, Cristina / Portilla, Joaquín / Peraire, Joaquim / Rivero, Antonio / Cervero, Miguel / Mariño, Ana / Poveda, Eva / Llibre, Josep M

    HIV medicine

    2022  Volume 23, Issue 8, Page(s) 825–836

    Abstract: Objectives: To pinpoint factors associated with low-level viraemia (LLV) and virological failure (VF) in people living with HIV in the era of high-efficacy antiretroviral treatment (ART) and widespread use of integrase strand transfer inhibitor (INSTIs)- ...

    Abstract Objectives: To pinpoint factors associated with low-level viraemia (LLV) and virological failure (VF) in people living with HIV in the era of high-efficacy antiretroviral treatment (ART) and widespread use of integrase strand transfer inhibitor (INSTIs)-based ART.
    Methods: We included adults aged > 18 years starting their first ART between 2015 and 2018 in the Spanish HIV/AIDS Research Network National Cohort (CoRIS). Low-level viraemia was defined as plasma viral load (pVL) of 50-199 copies/mL at weeks 48 and 72 and VF was defined as pVL ≥ 50 copies/mL at week 48 and pVL ≥ 200 copies/mL at week 72. Multivariable logistic regression models assessed the impact on LLV and VF of baseline CD4 T-cell count, CD4/CD8 T-cell ratio and pVL, initial ART classes, age at ART initiation, time between HIV diagnosis and ART initiation, gender and transmission route.
    Results: Out of 4186 participants, 3120 (76.0%) started INSTIs, 455 (11.1%) started boosted protease inhibitors (bPIs) and 443 (10.8%) started nonnucleoside reverse transcriptase inhibitors (NNRTIs), either of them with two nucleos(t)ide reverse transcriptase inhibitors (NRTIs). Low-level viraemia was met in 2.5% of participants and VF in 4.3%. There were no significant differences throughout the years for both virological outcomes. Baseline HIV-1 RNA > 5 log
    Conclusions: The rates of LLV and VF were low but remained steady throughout the years. Baseline HIV-1 RNA > 5 log
    MeSH term(s) Adult ; Anti-HIV Agents/therapeutic use ; Anti-Retroviral Agents/therapeutic use ; Antiretroviral Therapy, Highly Active ; HIV Infections/drug therapy ; HIV Integrase Inhibitors/therapeutic use ; HIV-1 ; Humans ; Integrase Inhibitors/therapeutic use ; RNA/therapeutic use ; Reverse Transcriptase Inhibitors/therapeutic use ; Viral Load ; Viremia/drug therapy
    Chemical Substances Anti-HIV Agents ; Anti-Retroviral Agents ; HIV Integrase Inhibitors ; Integrase Inhibitors ; Reverse Transcriptase Inhibitors ; RNA (63231-63-0)
    Language English
    Publishing date 2022-03-01
    Publishing country England
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 2001932-4
    ISSN 1468-1293 ; 1464-2662
    ISSN (online) 1468-1293
    ISSN 1464-2662
    DOI 10.1111/hiv.13265
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: Hepatitis aguda no colestásica como primera manifestación de sífilis secundaria.

    Rinascente, Chiara / Candela, Giancarlo / Cervero, Miguel / Lobato, Alejandro / Carbonell, Alejandro

    Revista de gastroenterología del Perú : órgano oficial de la Sociedad de Gastroenterología del Perú

    2015  Volume 35, Issue 3, Page(s) 247–249

    Abstract: We present a 34 year old male who enter the Digestive Department of the University Hospital Severo Ochoa in Madrid, Spain with jaundice with a great elevation of transaminases in relationship with an infectious syndrome that was correctly diagnosed and ... ...

    Title translation Acute non cholestatic hepatitis as the first manifestation of secondary syphilis.
    Abstract We present a 34 year old male who enter the Digestive Department of the University Hospital Severo Ochoa in Madrid, Spain with jaundice with a great elevation of transaminases in relationship with an infectious syndrome that was correctly diagnosed and treated with a very good outcome.
    Language Spanish
    Publishing date 2015-07
    Publishing country Peru
    Document type English Abstract ; Journal Article
    ISSN 1609-722X
    ISSN (online) 1609-722X
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: Changes in the immune response against SARS-CoV-2 in individuals with severe COVID-19 treated with high dose of vitamin D.

    Torres, Montserrat / Casado, Guiomar / Vigón, Lorena / Rodríguez-Mora, Sara / Mateos, Elena / Ramos-Martín, Fernando / López-Wolf, Daniel / Sanz-Moreno, José / Ryan-Murua, Pablo / Taboada-Martínez, María Luisa / López-Huertas, María Rosa / Cervero, Miguel / Coiras, Mayte

    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

    2022  Volume 150, Page(s) 112965

    Abstract: Main cause of severe illness and death in COVID-19 patients appears to be an excessive but ineffectual inflammatory immune response that may cause severe acute respiratory distress syndrome (ARDS). Vitamin D may favour an anti-inflammatory environment ... ...

    Abstract Main cause of severe illness and death in COVID-19 patients appears to be an excessive but ineffectual inflammatory immune response that may cause severe acute respiratory distress syndrome (ARDS). Vitamin D may favour an anti-inflammatory environment and improve cytotoxic response against some infectious diseases. A multicenter, single-blind, prospective, randomized clinical trial was approved in patients with COVID-19 pneumonia and levels of 25-hydroxyvitamin D (25(OH)D) of 14.8 ng/ml (SD: 6.18) to test antiviral efficacy, tolerance and safety of 10,000 IU/day of cholecalciferol (vitamin D
    MeSH term(s) Cholecalciferol/adverse effects ; Dietary Supplements ; Humans ; Immunity ; Prospective Studies ; Respiratory Distress Syndrome/drug therapy ; SARS-CoV-2 ; Single-Blind Method ; Vitamin D ; Vitamins/therapeutic use ; COVID-19 Drug Treatment
    Chemical Substances Vitamins ; Vitamin D (1406-16-2) ; Cholecalciferol (1C6V77QF41)
    Language English
    Publishing date 2022-04-14
    Publishing country France
    Document type Journal Article ; Multicenter Study ; Randomized Controlled Trial
    ZDB-ID 392415-4
    ISSN 1950-6007 ; 0753-3322 ; 0300-0893
    ISSN (online) 1950-6007
    ISSN 0753-3322 ; 0300-0893
    DOI 10.1016/j.biopha.2022.112965
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: Late HIV diagnosis among immigrants in Spain vs. native-born Spaniards, 2010-15.

    Gogishvili, Megi / Huang, Terry T-K / Costa, Sergio A / Florez, Karen / Mateu-Gelabert, Pedro / Valls, Maria R A / Rivero, María / Saumoy, Maria / Samperiz, Gloria / Cervero, Miguel / Pulido, Federico / Pérez, José A

    European journal of public health

    2021  Volume 31, Issue 6, Page(s) 1123–1128

    Abstract: Background: In 2012, the central government of Spain enacted Royal Decree-Law (RDL) 16/2012 and Royal Decree (RD) 1192/2012, which abolished universal healthcare coverage, thus limiting access to care for undocumented immigrants. Free health care was ... ...

    Abstract Background: In 2012, the central government of Spain enacted Royal Decree-Law (RDL) 16/2012 and Royal Decree (RD) 1192/2012, which abolished universal healthcare coverage, thus limiting access to care for undocumented immigrants. Free health care was also no longer granted to anyone who has never been employed. In this context, this study investigated the prevalence of late HIV diagnoses (LHDs) among immigrants living in Spain vs. native-born Spaniards.
    Methods: Data (n = 5943) from the 2010 to 2015 Cohort of the Spanish AIDs Research Network were used, including HIV-positive and antiretroviral therapy (ART)-naïve patients throughout Spain. Multivariate logistic models were fitted to compare the prevalence of LHD among the groups, adjusting for covariates.
    Results: The prevalence of LHD in the total sample was 39.5%. Compared with native-born Spaniards (n = 4445), immigrants (n = 1488) were more likely to have LHD (37.4% vs. 45.7%, respectively; P < 0.001). Multivariate analysis showed that the prevalence ratio of LHD among immigrants vs. native-born Spaniards was 1.15 [95% confidence interval (CI), 1.02-1.28], after adjusting for covariates. This disparity widened from 2010 to 2011 (APR = 1.14, 95% CI, 1.02-1.29) to 2012-15 (APR = 1.28, 95% CI, 1.17-1.39), although the change was not statistically significant.
    Conclusions: Immigrants in Spain had a higher risk of LHD compared with native-born counterparts. LHD is an important healthcare marker due to the positive benefits of early HIV diagnosis, including prevention, improvements in health outcomes and decreases in overall cost of treatment. More research is needed on the causes of the disparity and potential social and policy interventions to reduce the prevalence of LHD among immigrants.
    MeSH term(s) Emigrants and Immigrants ; HIV Infections/diagnosis ; HIV Infections/epidemiology ; Humans ; Indigenous Peoples ; Spain/epidemiology ; Undocumented Immigrants
    Language English
    Publishing date 2021-08-17
    Publishing country England
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 1129243-x
    ISSN 1464-360X ; 1101-1262
    ISSN (online) 1464-360X
    ISSN 1101-1262
    DOI 10.1093/eurpub/ckab089
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: Envejecimiento e influencia de la inversión del cociente CD4/CD8 en la incidencia de las comorbilidades y mortalidad de una cohorte de pacientes infectados por el virus de inmunodeficiencia humana.

    Cervero, Miguel / Torres, Rafael / Agud, Jose Luis / Pastor, Susana / Jusdado, Juan José

    Medicina clinica

    2016  Volume 146, Issue 5, Page(s) 189–193

    Abstract: Background and objective: It has been postulated that the inversion of the CD4:CD8 ratio as a hallmark of immunosenescence can be an independent factor that can herald the risk of co-morbidities. We studied the influence of aging and inversion of the ... ...

    Title translation Aging and influence of inversion of the CD4:CD8 ratio in the incidence of co-morbidities and mortality in a cohort of patients infected with human immunodeficiency virus.
    Abstract Background and objective: It has been postulated that the inversion of the CD4:CD8 ratio as a hallmark of immunosenescence can be an independent factor that can herald the risk of co-morbidities. We studied the influence of aging and inversion of the CD4:CD8 ratio in the incidence of comorbidities and mortality in the cohort of Hosptital Severo Ochoa.
    Methods: We analyzed the differences in the incidence rates of age-adjusted morbidities and evaluated the inversion of the CD4:CD8 ratio as predictor of mortality and development of comorbidities.
    Results: Age was associated with an increased incidence rate of diabetes mellitus, fractures, COPD and non-AIDS malignancies. We found an increased incidence rate of non-AIDS clinical events (OR 2.25; 95% CI 1.025-4.94) and AIDS events (OR 3.48; 95% CI 1.58-7.64) in individuals with CD4:CD8 ratio<0.7. Moreover, patients with a CD4:CD8 ratio<0.7 ratio had a higher risk of mortality (OR 5.96; 95% CI 0.73 to 48.40).
    Conclusion: It is important to detect and prevent non-AIDS comorbidities in the presence of a CD4:CD8 ratio<0.7.
    MeSH term(s) Adolescent ; Adult ; Aged ; Aging/immunology ; CD4-CD8 Ratio ; Comorbidity ; Female ; Follow-Up Studies ; HIV Infections/epidemiology ; HIV Infections/immunology ; Humans ; Incidence ; Male ; Middle Aged ; Prospective Studies ; Spain/epidemiology ; Young Adult
    Language Spanish
    Publishing date 2016-03-04
    Publishing country Spain
    Document type Journal Article
    ZDB-ID 411607-0
    ISSN 1578-8989 ; 0025-7753
    ISSN (online) 1578-8989
    ISSN 0025-7753
    DOI 10.1016/j.medcli.2015.10.014
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: Factores predictivos de las interacciones farmacológicas clínicamente significativas en los pacientes tratados con regímenes basados en inhibidores de proteasa, inhibidores de transcriptasa inversa no nucleósidos y raltegravir.

    Cervero, Miguel / Torres, Rafael / Jusdado, Juan José / Pastor, Susana / Agud, Jose Luis

    Medicina clinica

    2016  Volume 146, Issue 8, Page(s) 339–345

    Title translation Predictive factors of clinically significant drug-drug interactions among regimens based on protease inhibitors, non-nucleoside reverse transcriptase inhibitors and raltegravir.
    MeSH term(s) Adolescent ; Adult ; Aged ; Aged, 80 and over ; Anti-HIV Agents/adverse effects ; Anti-HIV Agents/therapeutic use ; Drug Interactions ; Drug Therapy, Combination ; Female ; Follow-Up Studies ; HIV Infections/drug therapy ; HIV Protease Inhibitors/adverse effects ; HIV Protease Inhibitors/therapeutic use ; Humans ; Logistic Models ; Male ; Middle Aged ; Multivariate Analysis ; Raltegravir Potassium/adverse effects ; Raltegravir Potassium/therapeutic use ; Retrospective Studies ; Reverse Transcriptase Inhibitors/adverse effects ; Reverse Transcriptase Inhibitors/therapeutic use ; Risk Factors ; Young Adult
    Chemical Substances Anti-HIV Agents ; HIV Protease Inhibitors ; Reverse Transcriptase Inhibitors ; Raltegravir Potassium (43Y000U234)
    Language Spanish
    Publishing date 2016-04-15
    Publishing country Spain
    Document type Journal Article
    ZDB-ID 411607-0
    ISSN 1578-8989 ; 0025-7753
    ISSN (online) 1578-8989
    ISSN 0025-7753
    DOI 10.1016/j.medcli.2016.01.016
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top